Brexit Solutions

Home > Clinical Services > Clinical Packaging > Brexit Solutions
UK EU
UK EU pic

Brexit solutions

Gateway to the UK and Europe

Brexit has brought about many structural and regulatory changes in the way that Britain does business with the world.

In spite of these challenges, Eramol is still perfectly placed as your global partner.

We are extremely well positioned to provide a seamless QP Release into the UK and mainland Europe, with our Irish facility providing a base for EU importation, EU QP Release and storage and distribution direct to trial sites. Solutions for Northern Ireland trial sites can also be evolved via Eramol’s Irish facility.

Enquire Today

In the United Kingdom, our facility provides QP Verification Services for IMPs imported from the EU. Eramol also offers a full ‘Importer of Record’ service, for the importation of products into both the UK and Ireland.

Eramol’s QPs also provide specialist regulatory and supply chain advice, enabling clients to navigate new and existing challenges in relation to UK and EU IMP supply.

Request chat with QP

Our Other Services

Formulation Development

Eramol offers clinical formulation development and manufacturing services to enable you to develop your product and speed up your time to market. We’ll work with you to develop an effective formulation – either in solid tablet, capsule or liquid form – giving you optimal clinical outcomes that can support your product across all clinical trial phases.

Sterile Manufacturing

Eramol delivers a purpose-built, EU GMP Annex 1–compliant sterile manufacturing service dedicated to Phase I and Phase II clinical trial supply. Our facility is designed for agility, reliability, and regulatory strength by integrating advanced isolator technology, closed-system processing, moist heat terminal sterilisation and a full end-to-end clinical supply chain — ensuring your sterile injectable, cartridges and pre filled syringes reach patients safely, on time and in full regulatory compliance.

Non Sterile Manufacturing

GMP Production of Tablets, Capsules & Oral Liquids for Phase I–III and Commercial Supply Eramol delivers end-to-end non-sterile manufacturing built on a foundation of quality, regulatory expertise, and Qualified Person (QP) leadership. Our Sevenoaks GMP facility, commissioned in November 2021 and operational since August 2022, supports the full product lifecycle—from early-phase clinical development right through to commercial supply.

Clinical Packaging

We recognise that the challenge of acquiring adequate placebos is considerable, whether it be matching a placebo or making an active comparator.

Labelling Solutions

Our versatile and extensive labelling solutions have been designed to offer flexibility, economy of scale and to meet the demands of last-minute requirements.

EU & UK QP Release

QP Release is a critical stage in clinical trials: it is the process whereby Qualified Persons (QPs) ensure that a batch of investigative medicinal products (IMPs) that has been manufactured are of a high enough quality that they can be released for use in clinical trials.

Reliable. Proven. Safe. Effective.

logoipsum
logoipsum
logoipsum-265
logoipsum-244
logoipsum-238 (1)
logoipsum-254
logoipsum-297

Reliable. Proven. Safe. Effective.

logoipsum
logoipsum
logoipsum-265
logoipsum-244
logoipsum-238 (1)
logoipsum-254
logoipsum-297

Speak With Us

Products on online services or over the Internet. Electronic commerce draws on
technologies such as mobile commerce application

Scroll to Top

Email

enquiry.uk@eramol.com

Phone

+44 (0) 1293 368080